ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Impact of the COVID-19 pandemic on the respiratory syncytial virus infections in children admitted with community acquired pneumonia: a retrospective study at a tertiary hospital of Northeast China.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe COVID-19 pandemic has markedly altered the infection landscape of various pathogens. This study aimed to evaluate the pandemic's impact on the infection dynamics of respiratory syncytial virus (RSV) among children with community acquired pneumonia (CAP).
methodsPediatric CAP patients were enrolled to compare the prevalence and characteristics of RSV infections before (2018-2019), during (2020-2022), and after (2023) the COVID-19 pandemic.
resultsA total of 991 RSV-positive and 6644 RSV-negative pediatric CAP patients were included. Key findings indicated that RSV-positive patients were younger and had fewer respiratory co-infections with specific pathogens. Following a notable decline in 2019, the RSV positivity rate increased significantly in 2020, then continuously decreased until 2022, and rebounded markedly in 2023. Compared to the pre-pandemic period, there were significant changes in the age distribution, gender composition, and co-infection patterns with specific pathogens among both RSV-positive and RSV-negative patients during and after the pandemic. Seasonal distribution of RSV positive patients and positivity rates in 2018 and 2019 typically peaked in winter. However, the seasonal patterns of RSV positive patients shifted significantly during and after the pandemic, characterized by a sharp decrease in February 2020, no resurgence at the end of 2022, and a delayed peak in April 2023. The seasonal trend of the positivity rate was also disrupted.
conclusionsThe COVID-19 pandemic has profoundly transformed the infection landscape of RSV in pediatric CAP patients, as evidenced by shifts in positivity rates, demographic characteristics, co-infection patterns, and seasonal trends.
Indexed as
Identifiers
40244454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.